Performance Of Amiodarone as a First-line Pharmacologic Agent to Treat New Onset Atrial Fibrillation in Patients with Sepsis and Septic Shock: A Retrospective Cohort Study in a Large U.S. Hospital System

Authors

Blerina Asllanaj, HCA HealthcareFollow
Elizabeth Benge, HCA HealthcareFollow
Don Pepito, HCA HealthcareFollow

Files

Division

Far West

Hospital

MountainView Hospital

Specialty

Internal Medicine

Document Type

Poster

Publication Date

2023

Keywords

amiodarone, antiarrhythmic medication, sepsis

Disciplines

Cardiovascular Diseases | Internal Medicine | Medicine and Health Sciences

Original Publisher

HCA Healthcare Graduate Medical Education

Comments

Research & QI Section

Recommended Citation

Asllanaj, Blerina; Benge, Elizabeth; and Pepito, Don, "Performance Of Amiodarone as a First-line Pharmacologic Agent to Treat New Onset Atrial Fibrillation in Patients with Sepsis and Septic Shock: A Retrospective Cohort Study in a Large U.S. Hospital System" (2023). Far West Division GME Research Day 2023. 1.
https://scholarlycommons.hcahealthcare.com/farwest2023/1